Motrin is owned by Kenvue (the United States, NYSE: KVUE), which was separated from Johnson & Johnson on 23 August 2023.[1][2] Before Kenvue, Motrin was owned by Johnson & Johnson from 2006 to 2023.[2]
Motrin is an ibuprofen brand introduced in 1974 as a prescription anti-inflammatory and moved over the counter in 1984. It is sold mainly in North America, where it competes directly with Advil, and it transferred from Johnson & Johnson to Kenvue in the 2023 separation.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.
No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Frequently asked questions
Who is the parent company of Motrin?
⌄
The parent company of Motrin is Kenvue, a publicly listed company headquartered in the United States.
Is Motrin American?
⌄
Yes. Motrin originated in the United States in 1974 and its owner, Kenvue, is also headquartered in the United States.
Since when has Kenvue owned Motrin?
⌄
Kenvue has owned Motrin since 23 August 2023.
Who owned Motrin before Kenvue?
⌄
Before Kenvue, Motrin was owned by Johnson & Johnson from 2006 until 2023.
Is Motrin still owned by Kenvue?
⌄
Yes. As of 16 September 2026, Motrin is still owned by Kenvue. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.